Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

The ointment effectively treats neurodermatitis and chronic eczema without causing skin irritation.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Intradermal testing can better detect corticosteroid allergies than patch testing.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.